NYRADA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.073 AUD | +28.07% |
|
+17.74% | +231.82% |
| 04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
| 04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NYRADA INC. | Other Pharmaceuticals | +28.07% | +17.74% | +231.82% | -9.88% | - | 6.79M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NYR Stock
- Charts Nyrada Inc.
- Comparison Chart
